FDA Perspective on Sofosbuvir Therapy for Patients With Chronic Hepatitis C Virus Genotype 1 Infection Who Did Not Respond to Treatment With Pegylated Interferon and Ribavirin

FDA Perspective on Sofosbuvir Therapy for Patients With Chronic Hepatitis C Virus Genotype 1 Infection Who Did Not Respond to Treatment With Pegylated Interferon and Ribavirin

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gastroenterology - Volume 147, Issue 6, December 2014, Pages 1196-1200

Poonam Mishra, Jeffry Florian, Karen Qi, Wen Zeng, Lisa K. Naeger, Eric Donaldson, Sarah Connelly, Jules O'Rear, Dionne Price, Jeffrey Murray, Debra Birnkrant,